By Pranav Kashyap and Purvi Agarwal (Reuters) -The UK’s benchmark FTSE 100 was little changed on Tuesday, as gains in pharma giant AstraZeneca were offset by declines in the automobile and parts sector, while investors indulged in some profit-taking ahead of a crucial domestic inflation reading. The blue-chip FTSE 100 lost 0.1%, while the mid-cap …
London’s FTSE 100 closes at one week-low ahead of CPI data Read More »
(Reuters) – Bitcoin rose to $70,206 at 20:03 GMT on Monday, adding $3,931 to its previous close. The world’s biggest and best-known cryptocurrency is up 82.3% from the year’s low of $38,505 on Jan. 23. Ether, the coin linked to the ethereum blockchain network, rose 13.3% on Monday to $3500. The approval and launch of …
By David Lawder FRANKFURT (Reuters) -U.S. Treasury Secretary Janet Yellen urged German bank executives on Tuesday to step up efforts to comply with sanctions against Russia and shut down efforts to circumvent them to avoid potential penalties themselves that would cut off dollar access. Yellen said at the start of a meeting with bankers that …
Yellen urges German banks to boost compliance with US sanctions on Russia Read More »
By Huw Jones LONDON (Reuters) -Artificial intelligence could be fundamentally disruptive but help boost productivity in Britain’s economy, posing a challenge to regulators who should be open to new rule-making approaches, a Bank of England (BoE) policymaker said on Tuesday. Britain has so far taken a cautious approach to formulating bespoke rules for AI, unlike …
New approaches may be needed to regulate AI, says Bank of England policymaker Read More »
By Aby Jose Koilparambil (Reuters) – Shares in British water firm Pennon fell 6% on Tuesday after the company missed annual operating profit forecasts and announced compensation for households in southern England affected by a parasite outbreak this month. The company said it would pay 3.5 million pounds ($4.45 million) in compensation, or about 215 …
UK’s Pennon to pay 3.5 million pounds compensation for Brixham water contamination Read More »
By Huw Jones LONDON (Reuters) -There is little evidence that big fee hikes imposed by U.S. duo Visa and Mastercard on retailers have led to a major improvement in service, Britain’s Payment Systems Regulator said on Tuesday, flagging concerns competition was not working. Visa and Mastercard have long dominated the market for payment cards, spurring …
Britain seeks to rein in Mastercard and Visa fees on retailers Read More »
MILAN (Reuters) – Italian insurer Generali said on Tuesday its first-quarter premiums and net profit beat analysts’ estimates, as the life segment returned to positive net flows and the non-life business showed a solid performance. Adjusted net profit was 1.12 billion euros ($1.22 billion) in the first quarter, beating the 979-million-euro analyst consensus provided by …
Generali beats estimates in Q1 as life business regains net inflows Read More »
LONDON (Reuters) – Britain’s once towering inflation rate looks set to fall close to the Bank of England’s 2% target on Wednesday, but it may be other figures in the data that influence the BoE’s decision on when to cut interest rates for the first time since 2020. Much of the drop in headline consumer …
Explainer: With inflation falling fast, will the BoE quickly cut rates? Read More »
By Stefano Rebaudo (Reuters) – The pound was within striking distance of its 2-month high versus the dollar on Tuesday but was set to break a seven-day winning streak against the euro ahead of key economic data. Closely-watched consumer price inflation data is due on Wednesday and “flash” PMI data on British business activity will …
Sterling set to break 7-day winning streak versus euro before data Read More »
By Jonathan Stempel (Reuters) -GSK has been sued by an independent Connecticut laboratory that accused the drugmaker of defrauding the U.S. government and taxpayers by concealing cancer risks in Zantac, once a blockbuster heartburn drug. In a whistleblower complaint filed on Monday, Valisure said GSK violated the federal False Claims Act by hiding the risks …
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk Read More »
